January 2006 Asthma - Asthma and allergy related news archives - January 2006

• Sinusitis One Of The Most Diagnosed Diseases In USA, American Academy Of Allergy, Asthma & Immunology (Medical News Today) - Thu, 29 Dec 2005 00:14:17 GMT
  Each year 35 million Americans are affected by chronic sinusitis, making it one of the most diagnosed diseases in the United States, according to the American Academy of Allergy, Asthma & Immunology (AAAAI)

• Asthma And Obesity Genetic Link Found (Medical News Today) - Sat, 31 Dec 2005 07:14:07 GMT
  A study about the relationship between asthma and obesity, which uses a community-based twin registry from the University of Washington in Seattle, has found a strong genetic link between the two disorders, according to findings published in the December issue of the Journal of Allergy and Clinical Immunology.

• Early asthma often leads to later lung trouble (Reuters) - Thu, 29 Dec 2005 19:33:56 GMT
  Asthma, usually defined as reversible airway obstruction, early in life may affect lung function later -- but whether or not these effects are reversible is not clear, Dr. N. Franklin Adkinson of the Johns Hopkins School of Medicine in Baltimore and colleagues point out in their report in the Journal of Allergy and Clinical Immunology.

• Early asthma often leads to later lung trouble (RedNova) - Thu, 29 Dec 2005 22:41:07 GMT
  NEW YORK (Reuters Health) - Adults with a history of childhood asthma frequently have irreversible deficits in lung function, a study shows.

• 35 million Americans suffer from sinusitis (UPI) - Sun, 01 Jan 2006 03:47:00 GMT
  NEW YORK, Dec. 31 (UPI) -- Each year 35 million American are affected by chronic sinusitis, making it one of the most diagnosed diseases in the United States.

• NIAID researchers show functioning of promising TD drug (PharmaBiz) - Fri, 30 Dec 2005 02:52:20 GMT
  Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB). The finding may help scientists optimise the drug candidate, PA-824, which targets mycobacterium tuberculosis (M. tb).

• Overcast Skies Are Trapping City's Particulate Pollution (RedNova) - Sat, 31 Dec 2005 15:57:26 GMT
  By Tony Davis, ARIZONA DAILY STAR Colder weather again brings visit from ugly shroudTucson's air has been thick with haze full of lung-irritating particulates the past few days.A heavy cloud cover during much of the past few days has trapped air pollution from cars, holiday delivery trucks, fireplaces and other sources close to the ground when they would normally rise and dissipate.

• Label law a lifesaver to the allergy prone (Times Herald) - Thu, 05 Jan 2006 12:37:23 GMT
  Ray and Diana Brogan are label-conscious. Cow-milk products can make their 9-year-old daughter Alexandria's skin spot. Wheat makes Alexandria and her brother, John, 6, hyper.

• Some health issues possible from fires (The Oklahoman) - Thu, 05 Jan 2006 11:56:15 GMT
  Jan 05, 2006: Smoke particles from recent fires may be contributing to asthma, allergies and other breathing problems for some Oklahomans, but health risks are low for most healthy people, experts said.

• State Laws Allow Students To Carry Asthma, Anaphylaxis Medications, USA (Medical News Today) - Sat, 31 Dec 2005 17:14:07 GMT
  State laws are changing to allow students with asthma and anaphylaxis to carry and self-administer lifesaving medications at school. Allergy & Asthma Network Mothers of Asthmatics (AANMA) has launched a national campaign to educate students, parents, healthcare providers and school staff about these new laws and help students self-manage their diseases.

• MEDIA ALERT: Managing Asthma (AAAAI.org) - Thu, 05 Jan 2006 21:07:56 GMT
  Asthma affects approximately 20 million Americans and is responsible for nearly 5,000 deaths a year. There are 2 million asthma-related visits to emergency departments each year for asthma.

• Reducing exposure can reduce symptoms of occupational asthma (AAAAI.org) - Thu, 05 Jan 2006 20:37:56 GMT
  MILWAUKEE-Americans experiencing symptoms of allergies or asthma in the workplace, might actually be allergic to work. Up to 150f adult asthma cases in the United States have job-related factors, and it accounts for approximately 24.5 million missed work days annually.

• Smoke from grass fires bothering some allergy sufferers and asthmatics (Waco Tribune-Herald) - Fri, 06 Jan 2006 07:08:14 GMT
  The good news for allergy and asthma sufferers who have been sneezing and wheezing due to smoke from recent grass fires is that the situation is temporary. The bad news is that the only way to avoid the discomfort is to stay indoors, physicians say.

• Nonprescription Inhaler Effective for Asthma (RedNova) - Fri, 06 Jan 2006 21:37:21 GMT
  NEW YORK (Reuters Health) - In a small study of patients with nighttime asthma, a nonprescription inhaler containing epinephrine was nearly as effective as a prescription inhaler dispensing albuterol in terminating an acute asthma flare-up.It is widely believed that nonprescription epinephrine inhalers are less effective and have more adverse effects on the heart than prescription drugs like

• Nonprescription inhaler effective for asthma (Reuters) - Fri, 06 Jan 2006 20:48:42 GMT
  It is widely believed that nonprescription epinephrine inhalers are less effective and have more adverse effects on the heart than prescription drugs like albuterol, Dr. Leslie Hendeles and colleagues write in the Annals of Allergy, Asthma, and Immunology.

• ICS most effective for persistent asthma in children (EurekAlert!) - Tue, 10 Jan 2006 14:40:16 GMT
  While both inhaled corticosteroids (ICS) and leukotriene receptor antagonists (LTRA) have been proven to help control mild-to-moderate persistent asthma in school-age children, a new study shows ICS may be the more effective treatment.

• Asthma- Suffocating Lives (BellaOnline) - Wed, 11 Jan 2006 06:54:12 GMT
  Asthma is a chronic disease in which the patient suffers from periodic attacks of wheezing and has difficulty in breathing, especially inhaling. The cause of asthma is the blockage of the air passage to lungs when mucus or muscle spasm gets accumulated on the inner sides.

• Common Asthma Medication Poses Risk to Black Patients (Health Scout) - Wed, 11 Jan 2006 16:19:01 GMT
  Study found likelihood of asthma-related deaths slightly higher with salmeterol.

• CONCERN OVER SPECIALIST ALLERGY CENTRE (Isle of Wight County Press) - Wed, 11 Jan 2006 09:59:47 GMT
  By Suzanne Pert A TRUSTEE of the David Hide Asthma and Allergy Research Centre has expressed concern that it remains without a clinical specialist since the departure some months ago of Dr Hassan Arshad.

• Common Asthma Medication Poses Risk to Black Patients (InteliHealth) - Thu, 12 Jan 2006 05:44:13 GMT
  (The New York Times News Service) -- A large study on the popular asthma medication salmeterol was halted after researchers uncovered evidence that the drug may pose a slightly higher risk for respiratory and asthma-related deaths among black patients.

• ICS Most Effective For Persistent Asthma In Children (Science Daily) - Thu, 12 Jan 2006 05:06:56 GMT
  While both inhaled corticosteroids (ICS) and leukotriene receptor antagonists (LTRA) have been proven to help control mild-to-moderate persistent asthma in school-age children, a new study in the January 2006 issue of the Journal of Allergy & Clinical Immunology shows ICS may be the more effective treatment.

• Genentech said to halt allergy tests (CNN Money) - Mon, 16 Jan 2006 13:33:41 GMT
  Genentech Inc. put a stop to a clinical trial for a potential treatment for peanut allergies after two children suffered "severe" reactions during tests, according to a news report published Monday.

• Without precautions, cold spells can trigger asthma attacks (phillyburbs.com) - Sat, 14 Jan 2006 19:10:20 GMT
  TRENTON, N.J. - Mom's advice about bundling up in the cold is especially important for the growing number of people with asthma.

• Genentech halts study of drug for peanut allergy (Sacramento Business Journal) - Mon, 16 Jan 2006 22:54:49 GMT
  South San Francisco biotech giant Genentech Inc. has pulled its test of a drug to prevent reactions to peanut allergy. The company, which has a plant in Vacaville, cited concerns for the safety with an allergy test, not with the drug itself.

• Peanut allergy trial of Xolair halted (UPI) - Mon, 16 Jan 2006 20:57:01 GMT
  SAN FRANCISCO, Jan. 16 (UPI) -- A clinical trial of the drug Xolair as a way to prevent peanut allergy reactions was halted over safety concerns with an allergy test, a report said.

• Genentech halts allergy drug trial (Inside Bay Area) - Tue, 17 Jan 2006 12:13:35 GMT
  Biotechnology company Genentech of South San Francisco has stopped a clinical trial of a peanut-allergy treatment over safety concerns about some reactions and not the drug itself.

• Safety Concerns Halt Peanut-Allergy Drug (ABC News) - Wed, 18 Jan 2006 00:14:28 GMT
  Safety Concerns Halt Genentech Peanut-Allergy Drug Development

• Safety Concerns Halt Peanut-Allergy Drug (San Francisco Chronicle) - Wed, 18 Jan 2006 00:25:21 GMT
  Biotechnology company Genentech Inc. has stopped development of a promising peanut-allergy treatment because of safety concerns raised during human experiments, a company spokesman said Tuesday. Genentech officials stopped development of the drug last...

• Study targets better asthma treatments (UPI) - Wed, 18 Jan 2006 01:42:21 GMT
  SAN DIEGO, Jan. 17 (UPI) -- A study by California researchers says inhaled corticosteroids may be more effective than other treatments for mild-to-moderate childhood asthma.

• Genentech Halts Trial of Allergy Drug (Los Angeles Times) - Tue, 17 Jan 2006 08:05:34 GMT
  Genentech Inc., the world's second-biggest biotechnology company, stopped a clinical trial of a peanut-allergy treatment over safety concerns about some reactions and not the drug itself.

• Health Alert: Asthma and ozone (WIS-TV Columbia) - Tue, 17 Jan 2006 20:36:44 GMT
  (National) January 17, 2006 - Valerie Riecke lives a pretty normal life, but deals with asthma daily. She says she takes medicine twice a day, and during certain times of year, she's more susceptible to illness because of it.

• ICS Most Effective for Persistent Asthma in Children (Newswise) - Tue, 17 Jan 2006 15:21:41 GMT
  While both inhaled corticosteroids (ICS) and leukotriene receptor antagonists (LTRA) have been proven to help control mild-to-moderate persistent asthma in school-age children, a new study shows ICS may be the more effective treatment.

• Safety Concerns Halt Peanut-Allergy Drug (ABC News) - Wed, 18 Jan 2006 15:44:09 GMT
  Safety Concerns Halt Genentech Peanut-Allergy Drug Development

• Safety Concerns Halt Peanut Allergy Study (WKYT 27 - Kentucky) - Wed, 18 Jan 2006 23:00:11 GMT
  Safety concerns raised during human trials have prompted San Francisco-based biotech company Genentech Inc. to halt development of a promising peanut allergy treatment called Xolair.

• Study Targets Better Asthma Treatments (RedNova) - Wed, 18 Jan 2006 03:31:43 GMT
  A study by California researchers says inhaled corticosteroids may be more effective than other treatments for mild-to-moderate childhood asthma. The study, published in the January issue of the Journal of Allergy & Clinical Immunology, was led by Robert S. Zeiger M.D.

• Dynavax's Stock Jumps On Positive Allergy Drug Data (BioWorld) - Fri, 20 Jan 2006 04:11:10 GMT
  Shares of Dynavax Technologies Corp. jumped 34 percent after the company reported two-year data from a Phase II/III trial showing that its disease-modifying allergy drug, Tolamba, significantly reduced symptoms compared to placebo.

• Study Compares Kids' Asthma Drugs (HealthCentral.com) - Fri, 20 Jan 2006 11:58:23 GMT
  THURSDAY, Jan. 19 (HealthDay News) -- Inhaled corticosteroids are more effective than another class of drugs called leukotriene receptor antagonists (LTRAs) in treating persistent asthma in school-age children, a new study concludes.

• Study Compares Kids' Asthma Drugs (MedicineNet.com) - Fri, 20 Jan 2006 20:21:25 GMT
  Title: Study Compares Kids' Asthma Drugs Category: Health News Created: 1/20/2006 1:58:00 AM Last Editorial Review: 1/20/2006 1:58:27 AM

• Genentech halts allergy drug trial (San Jose Mercury News) - Sat, 21 Jan 2006 05:44:55 GMT
  Biotechnology company Genentech has stopped development of a promising peanut-allergy treatment because of safety concerns raised during human experiments, a company spokesman said Tuesday.

• Lifestyle Changes to Manage Asthma (ThirdAge) - Mon, 23 Jan 2006 07:20:32 GMT
  Making some lifestyle changes can help you avoid triggers that may cause an asthma attack. Because there are many types of allergens that may trigger asthma, it is nearly impossible to completely eliminate all allergens from your environment.

• OTC asthma inhalers on the verge of extinction (CNN Money) - Tue, 24 Jan 2006 19:18:41 GMT
  An FDA advisory committee voted to take away over-the-counter status for asthma inhalers that use the ozone-depleting chemical epinephrine on Tuesday, but the vote is not a final decision.

• Some asthma inhalers could be banned (ABC 13 Texas) - Wed, 25 Jan 2006 00:48:08 GMT
  Asthma sufferers who rely on over the counter asthma inhalers could soon be forced to turn to prescriptions.

• FDA recommends ban on nonprescription asthma inhalers (Billings Gazette) - Tue, 24 Jan 2006 23:13:25 GMT
  WASHINGTON -- Millions of nonprescription inhalers used for decades by asthma sufferers, often against the advice of doctors, could be taken off drugstore shelves because they contain propellants that harm the ozone layer. An advisory panel voted 1...

• Asthma Inhaler That Harms Ozone May Be Phased Out (NBC 10 Philadelphia) - Tue, 24 Jan 2006 21:50:06 GMT
  An asthma medication that's been around for decades may soon be missing from pharmacy shelves.

• FDA panel recommends federal ban on nonprescription asthma inhalers that harm ozone (KARE 11 Minneapolis-St. Paul) - Tue, 24 Jan 2006 19:56:08 GMT
  Certain types of nonprescription inhalers used for decades by asthma sufferers, often against the advice of doctors, could be taken off drugstore shelves

• FDA Panel Recommends Federal Ban on Nonprescription Asthma Inhalers That Harm Ozone (WAVY 10) - Tue, 24 Jan 2006 19:24:58 GMT
  (AP) - Certain types of nonprescription inhalers used for decades by asthma sufferers, often against the advice of doctors, could be taken off drugstore shelves because they contain propellants that harm the ozone layer.

• Allergy cell holds treatment hope (BBC News) - Mon, 23 Jan 2006 07:56:01 GMT
  Scientists say they have found how a cell involved in allergy is made, which may help with finding new treatments.

• FDA Panel Calls for Ban on Some Asthma Inhalers (Health Scout) - Wed, 25 Jan 2006 01:18:39 GMT
  Certain over-the-counter products contain chemical that can damage ozone layer.

• FDA Panel Calls for Ban on Some Asthma Inhalers (MedicineNet.com) - Wed, 25 Jan 2006 20:20:28 GMT
  Title: FDA Panel Calls for Ban on Some Asthma Inhalers Category: Health News Created: 1/25/2006 1:58:00 AM Last Editorial Review: 1/25/2006 1:58:27 AM

• FDA panel recommends federal ban on nonprescription asthma inhalers that harm ozone (Sioux City Journal) - Thu, 26 Jan 2006 06:28:37 GMT
  WASHINGTON (AP) -- Millions of nonprescription inhalers used for decades by asthma sufferers, often against the advice of doctors, could be taken off drugstore shelves because they contain propellants that harm the ozone layer.

• Asthma Sufferers Especially Vulnerable To Flu (WAVE 3 Louisville) - Thu, 26 Jan 2006 01:02:09 GMT
  The flu season has yet to hit Kentuckiana, but it's a good bet that it soon will. It's still not too late to be vaccinated, and as Medical Reporter Lori Lyle explains, people who suffer from asthma need the protection the flu vaccine can provide.

• FDA panel recommends federal ban on nonprescription asthma inhalers that harm ozone (Picayune Item) - Thu, 26 Jan 2006 16:43:37 GMT
  WASHINGTON (AP) - Certain types of nonprescription inhalers used for decades by asthma sufferers, often against the advice of doctors, could be taken off drugstore shelves because they contain propellants that harm the ozone layer.

• FDA wants asthma drug withdrawn (News-Medical-Net) - Thu, 26 Jan 2006 20:12:56 GMT
  An FDA advisory panel has advised that an over-the-conter (OTC) asthma drug should be withdrawn.

• LENOIR FIRM AIMS TO TRANSFORM INDUSTRY WITH SHOT-FREE ALLERGY TREATMENT: Growth in air for Greer (The Charlotte Observer) - Sat, 28 Jan 2006 11:04:23 GMT
  Growth in air for Greer Leigh Dyer LENOIR -- Those who find themselves on a tour of Greer Laboratories should be careful which doors they open. Especially if they suffer from allergies.

• Growth in Air for Greer: Lenoir Firm Aims to Transform Industry With Shot-Free Allergy Treatment (RedNova) - Sat, 28 Jan 2006 19:46:16 GMT
  By Leigh Dyer, The Charlotte Observer, N.C. Jan. 28--LENOIR -- Those who find themselves on a tour of Greer Laboratories should be careful which doors they open. Especially if they suffer from allergies. Behind some are rows of jars of pungent-smelling mold.

• NATA dealing with asthma is athletes (Oroville Mercury-Register) - Sun, 29 Jan 2006 22:30:28 GMT
  If exposure to the problem of asthma in athletics isn't at an all-time high, it may be approaching that point.

• Penn To Test New Thermal Energy Procedure To Reduce Asthmatic Symptoms (Science Daily) - Tue, 31 Jan 2006 17:09:17 GMT
  Up until now, if you suffer from asthma, medication has been the only treatment available to you for relief. But now, clinical researchers at the Hospital of the University of Pennsylvania (HUP) hope to open up a new avenue to alleviate the debilitating symptoms of asthma - through an investigative bronchoscopic procedure where the smooth muscle of the airway, which causes the spasm, is reduced

• Merck results better than expected (Reuters) - Tue, 31 Jan 2006 15:55:40 GMT
  NEW YORK (Reuters) - Merck & Co. MRK.N posted better-than-expected fourth-quarter results on Tuesday, boosted by cost-cutting and strong demand for its asthma and cholesterol medicines.

Similar Pages

Yes
(Added: 26-Feb-2006 Rating: 0 Votes: 0) Rate It
[0] View Comment